Rep. Jonathan Jackson’s $50K Palantir Purchase Sparks Conflict Concerns After 8% Stock Drop

PLTRPLTR

Rep. Jonathan Jackson purchased $15,001 to $50,000 of Palantir shares on December 22, 2025, disclosed within the required reporting window. The stock has fallen over 8% since the trade, and Jackson’s role on the House Foreign Affairs Committee raises potential conflict-of-interest and contract award scrutiny.

1. U.S. Lawmaker’s Palantir Purchase Draws Scrutiny

In late December 2025, Representative Jonathan Jackson reported acquiring between $15,001 and $50,000 worth of Palantir shares, a transaction now under the microscope due to his seat on the House Foreign Affairs Committee. Since the disclosed purchase date of December 22, Jackson’s stake has declined more than 8%, reflecting broader weakness in PLTR’s early-2026 performance. Observers note that Palantir derives approximately 40% of its annual revenue from U.S. federal agencies—including the Department of Defense and intelligence services—sectors directly influenced by Jackson’s legislative purview, heightening concerns over potential conflicts of interest despite compliance with disclosure regulations.

2. Q4 Earnings Preview Highlights Robust Palantir Growth

As Palantir prepares to report fourth‐quarter results, consensus analyst estimates project revenue of $1.12 billion, up 62% year-over-year, and adjusted earnings per share of $0.27, representing a 64.1% increase versus Q4 2024. The company’s expanding base of government and commercial contracts, including new AI deployments for defense analytics and supply-chain optimization, underpins the forecasted acceleration. With a gross margin near 81% and recurring subscription revenues comprising over 60% of total sales, Palantir is poised to maintain its high surprise history—having exceeded estimates in 8 of the last 10 quarters—while investors watch closely for any guidance on profitability inflection points.

3. Hedge Fund Manager Englander Trims Palantir on Valuation Concerns

During the third quarter, Millennium Management—led by billionaire Israel Englander—reduced its Palantir position by selling approximately 4.5 million shares, citing the stock’s premium valuation as the primary rationale. At the time, PLTR traded at roughly 110 times trailing sales, making it the most expensive software name in the S&P 500 by a wide margin. Despite Palantir’s 63% revenue growth to $1.1 billion in Q3 2025 and non-GAAP net income doubling to $0.21 per share, Englander’s team opted to reallocate capital toward opportunities with more moderate multiples, underscoring concerns that even strong top-line momentum may not justify current pricing.

Sources

FFIFF
+5 more